Page 89 - Sohini Das

RT-PCR kit makers tweaking kits to detect new coronavirus strains

The country's apex health research body, Indian Council of Medical Research (ICMR), is receiving proposals from kit makers in this regard

CoWin registration from 9am today as India enters next phase of vaccination

The private sector is poised for a bigger and more active role in administering the life-saving jab.

Bharat Biotech signs deal to send 20 mn Covaxin doses to Brazil

Shipments to be made during second and third quarters of current calendar

Hospitals turn to pre-Covid biz as patients prefer home quarantine

The number of Covid beds dropped to 1,600 during the third quarter, and further dropped to 800 in January

PLI scheme: Pharma industry expects more guidelines on investment

B R Sikri, chairman of the Federation of Pharma Entrepreneurs, said, higher incentives would have meant more production of cancer drugs, thereby, bringing down their prices

Centre announces Rs 15,000 crore PLI for pharma, IT hardware sectors

Pharma scheme aims at Rs 3 trillion incremental sales, 100,000 jobs; experts say hardware scheme to help India become electronics manufacturing hub for the world

Ukraine keen on Bharat Biotech's Covaxin, sends team to negotiate supply

Three-member delegation led by nation's health minister visits Hyderabad unit, discusses timeline for delivery of shots on priority, and prospects of a tie-up for teh firm;s intranasal vaccine

Expert panel asks DRL to come back with more data on Sputnik safety

DRL applied for restricted emergency use of Sputnik V last week, has lined up 250 mn doses for Indians over next 12 months

Ventilator companies scramble for other ways to utilise capacities

Doctors are now shifting treatment protocol for Covid-19 at hospitals and invasive ventilation is not being preferred

Can re-engineer Covaxin to beat South African variant: Bharat Biotech

Other vaccine makers, such as Hyderabad-based Biological E, too, have started working on different strains.

Bharat Biotech to have phase 3 efficacy data for Covaxin in 2 weeks

The restricted emergency use allowed by the regulator was based on phase 2 safety and immunogenicity studies, as well as data from monkey trials

Serum Institute to export Covid-19 vaccine to 25-30 countries on Tuesday

Bharat Bio says keen to follow, have capacity of 40 mn doses a month

Covid-19 pandemic: Plasma therapy gets thumbs down from expert panel

The absence of drugs to target the Sars-CoV-2 virus had triggered research on repurposed drugs, as well as biologics

States shying away from administering Bharat Bio's Covid-19 vaccine Covaxin

A month on, 21 states and UTs have not administered a single shot of the vaccine

With WHO backing, SII to ship Astra Covid-19 vaccine to 70 countries

After audit of Pune plant, Serum may supply vaccines to UK as well

More Covid vaccine supplies lined up as India gets ready for Phase 3 drive

Bharat Bio may add 200 mn doses if needed; Serum to have 2.5 mn capacity by year-end

Covid-19 vaccination: Ready for round-3, but no decision on who'll pay

Public vaccination back-end technology in place, private sector role likely in procuring doses for staff

Govt likely to allow Covid-19 vaccine in private market by March end

Low turnout for vaccination so far a likely reason

Russia's Sputnik V 91.6% effective with good safety profile in trials

In the interim efficacy analysis, data from 19,866 volunteers were included

Bharat Biotech inks pact to commercialise Covid-19 vaccine Covaxin in US

Ocugen, a Nasdaq-listed firm, focuses on developing and commercialising gene therapies to cure blindness diseases